Several clinical trials are assessing therapies that are applied within 2 weeks after injury.
These include activated macrophages (which may help repair the injured cord), alternating currents (to stimulate regeneration), and AIT-082 (a drug that may stimulate growth factors and stem cell proliferation).
The macrophage trial is limited to people with “complete” thoracic spinal cord injury and requires surgery.
Please consider the risk and benefits of the trial carefully, including the risk of moving somebody to another center.
